Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of ...

The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

How an excessive focus on methods has distracted attention from the more fundamental challenge of building rigor and learning ...

In this live interview on Bloomberg World, Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma, discusses the ...

The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, ...

For people living with atopic dermatitis, the real test of any new therapy is not what it can do in a few months, but whether it can keep angry, inflamed skin quiet over the long haul. Nektar ...

Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development ...

Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" o ...

Real-world data (RWD) and real-world evidence (RWE) are reshaping clinical trials by identifying the patients most likely to benefit from new treatments, allowing sponsors to design studies that are ...